The Cooper Cos., Inc.

The Cooper Cos., Inc.

The Cooper Cos., Inc.

Overview
Date Founded

1958

Headquarters

6140 Stoneridge Mall Road, Suite 590, Pleasanton, CA, 94588, USA

Type of Company

Public

Employees (Worldwide)

11.8K

Industries

Medical Products & Equipment
Wholesale: Medical Supplies & Pharmaceuticals
Hospitals & Patient Services

Company Description

The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision (CVI) and CooperSurgical (CSI). CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, CA, Cooper has over 7,500 employees with products sold in over 100 countries

Contact Data
Trying to get in touch with decision makers at The Cooper Cos., Inc.? Subscribe today to access their professional contact information.
Executives & Employees

President & Chief Executive Officer

Senior Vice President, Chief Financial Officer & Treasurer

Chief Operating Officer & Executive Vice President

Vice President, General Counsel & Secretary

Executive Vice President, Secretary, Chief Administrative Officer & Chief Governance Officer

Chief Strategy Officer & Executive Vice President

President of Coopersurgical, Inc

Executive Vice President, Coopervision, Inc

Chief Accounting Officer & Senior Vice President, Finance & Tax

Vice President, Investor Relations & Administration

Board of Directors

Former President, Chief Executive Officer, Director, Chairman & Chief Operating Officer at The Cooper Cos., Inc.

Co-Founder at Children's Tumor Foundation

President & Chief Executive Officer at S-G Management LLC

Former President at Opera San Jose

Associate Professor, Department of Obstetrics & Gynecology at New York University - School of Medicine

Senior Executive on Loan to Catalyst, Inc at Procter & Gamble Co.

Former Vice President & Chief Operating Officer at Becton, Dickinson & Co.

Paths to The Cooper Cos., Inc.
Potential Connections via
Relationship Science
You
The Cooper Cos., Inc.
Owners & Shareholders
Details Hidden

Generation Investment Management Generation is an independent, private, owner-managed partnership with offices in London and New York. The firm was co-founded in 2004 by Al Gore and David Blood. Team The Generation team of 55 people represents 16 countries and speaks over 21 languages. Our investment team was founded by bringing together seasoned investment analysts and leaders from the sustainability research field. Today these skills are integrated into Generation's team of 25 investment professionals who have over 150 years of combined investment experience. Sustainable Investing for the Long Term Generation's investment approach is based on the idea that sustainability factors—economic, environmental, social and governance criteria—will drive a company's returns over the long term. By integrating sustainability issues with traditional analysis, we seek to provide superior investment returns.* We are closely aligned with our clients, and our performance is measured over the long term. A Unique Research Platform to Analyze Global Challenges Generation has built a global research platform to integrate sustainability research into fundamental equity analysis. We focus on key drivers of global change, including climate change and environmental degradation; poverty and development; water and natural resource scarcity; pandemics and healthcare; and demographics, migration and urbanization. These global challenges pose risks and opportunities that can materially affect a company's ability to sustain profitability and deliver returns. Our research plays an important role in forming our views on the quality of the business, the quality of management and valuation. A Diverse Advisory Board Our Advisory Board, convened by our Chairman Al Gore, helps set our long term thematic research agenda into global sustainability issues. The Advisory Board is a diverse set of global thinkers who help us anticipate the changing context for business. Vision Generation's vision is to embed sustainability into the mainstream capital markets, and our core values reflect a commitment to responsible citizenship. Five percent of the profitability of the firm is allocated to the Generation Foundation, which will support global non-profit sustainability initiatives.

Details Hidden

Bessemer Investment Management (BIM) manages separate client-focused equity, fixed-income and balanced portfolios. The firm also manages a variety of mutual funds and hedge funds. The firm invests globally in the public equity and fixed-income markets and also in the alternative markets. Their alternative investments are typically limited to hedge funds, real estate and private equity. ^BIM directly manages core strategies including global large-cap and mid-cap equities, US fixed-income, convertible bonds and commodities. For asset classes requiring unique expertise, such as global small-cap equities, global fixed-income, hedge funds, real estate and private equity, the firm selects external investment managers. ^BIM's fixed-income investments include cash and short-term securities, taxable bonds, municipal bonds and investment-grade securities. The firm's investment approach is based on a combination of top-down and bottom-up fundamental and quantitative analysis. They use both in-house and external research to support their investment decisions. Portfolio managers actively manage the traditional asset classes and use a fund-of-funds approach for their alternative investments.

Details Hidden

Westfield Capital Management (WCM) is a growth manager that seeks to invest in the reasonably priced stocks of companies with high earnings potential. The firm uses fundamental, bottom-up research to identify growth companies across all market-caps. They seek to identify companies capable of providing consistently high or accelerating earnings growth. WMC supervises mainly investments in publicly traded, domestic growth equities, with investment products focusing on each segment of the capitalization spectrum. The firm also supervises investments in foreign equities that are traded on US stock exchanges and in US dollars, American Depositary Receipts (ADRs), American Depositary Shares (ADS), and Global Depositary Receipts (GDRs).WMC's investment strategies include: Large Cap Growth, Small/Mid Cap Growth, Mid Cap Growth, All Cap Growth, Dividend Growth, Sustainable Growth, Micro Cap, and Select Growth Equity. The following strategies are closed to new investors: Small Cap Growth, Fixed Income, and Life Sciences.With the exception of their Mid Cap Strategy, WMC does not generally invest in derivatives, options, or privately held securities, and does not permit short selling. The Micro-Cap Strategy permits the usage of leveraging techniques, short selling, frequent trading, investments in private securities, and investments in derivatives or options. As such, the Micro-Cap Strategy will enter into a short position in a broad market index ETF. Under normal market conditions, the firm's long-only equity products don't use a frequent trading strategy; however, in certain market conditions, trading activity within products may increase.

Recent Transactions
Details Hidden

The Cooper Cos., Inc., CooperSurgical, Inc. purchase LifeGlobal Group LLC

Details Hidden

The Cooper Cos., Inc., CooperVision, Inc. purchase Paragon Vision Sciences, Inc. from Bausch Health Cos., Inc.

Details Hidden

The Cooper Cos., Inc., CooperSurgical, Inc. purchase Teva Pharmaceutical Industries Ltd. /Paragard Bus from Teva Pharmaceutical Industries Ltd.

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Accountant

Advised onThe Cooper Cos., Inc. purchases Biocompatibles Eyecare, Inc. from Biocompatibles International Ltd.

Accountant

Advised onThe Cooper Cos., Inc. purchases Aspect Vision Care Ltd.

Legal Advisor

Advised onThe Cooper Cos., Inc. purchases Ocular Sciences, Inc.

Lender

Advised onThe Cooper Cos., Inc. purchases Sauflon Pharmaceuticals Ltd. from Hollyport Capital LLP

Associate

Advised onThe Cooper Cos., Inc. purchases Sauflon Pharmaceuticals Ltd. from Hollyport Capital LLP

Lender

Advised onThe Cooper Cos., Inc. purchases Sauflon Pharmaceuticals Ltd. from Hollyport Capital LLP

Advisors & Consultants
Legal Advisor

Co-Chair, Automotive Industry Group at Latham & Watkins LLP

Legal Advisor

Partner at Latham & Watkins LLP

Legal Advisor

Partner at Latham & Watkins LLP

Clients

National Vision Holdings, Inc. engages in optical retail. It specializes in eye care and eyewear. It operates through Owned and Host, and Legacy segment. The Owned and Host segment includes two brands, America's Best and Eyeglass World, and Vista Optical locations in Fred Meyer stores. The Legacy segment involves in the operation of inventory and laboratory processing services to vision centers in Walmart retail locations. The company was founded in 1990 and is headquartered in Duluth, GA.

UDG Healthcare Plc engages in the supply and distribution of pharmaceutical and medical products. It operates through the following segments: Ashfield, Sharp, and Aquilant. The Ashfield segment provides commercialization services for the pharmaceutical and healthcare industry. The Sharp segment offers contract packaging and clinical trial packaging services. The Aquilant segment involves. outsourced sales, marketing, distribution, and engineering services to the medical and scientific sectors. The company was founded in 1948 and is headquartered in Dublin, Ireland.

Key Stats and Financials As of 2017
Market Capitalization
$12.3B
Total Enterprise Value
$13B
Earnings Per Share
$7.52
Revenue
$2.14B
Enterprise Value Sales
6.08x
Debt TEV
0.09x
Total Debt
$1.17B
Total Equity
$3.18B
Net Profit
$373M
EBITDAMargin
31.32%
Enterprise Value EBITDAOperating
19.4x
TEVNet Income
34.86x
EBITDA
$670M
Three Year Compounded Annual Growth Rate Of Revenue
7.58%
Five Year Compounded Annual Growth Rate Of Revenue
8.16%
Investments
Details Hidden

GestVision, Inc. provides care diagnostic test for preeclampsia. It delivers insights for safer pregnancies beginning with a diagnostic for preeclampsia, a poorly understood pregnancy- related condition. The firm is developing a point of care diagnostic product that provides essential information to OBGYNs for improving patient management and outcomes. The company was founded in 2014 by Wendy L. Davis and is headquartered in Guilford, CT.

Suppliers
American Software Inc. Computer Software | Atlanta, GA

American Software (NASDAQ: AMSWA) provides demand-driven supply chain management and enterprise software solutions backed by more than 40 years of industry experience that drive value for companies regardless of market conditions. American Software, Inc. (American Software) develops, markets and supports a portfolio of software and services that deliver enterprise management and collaborative supply chain solutions to the global marketplace. The Company's software and services are designed to bring business value to enterprises by supporting their operations over intranets, extranets, client/servers or the Internet. It provides software solutions through three business segments, which are broken down into four product and service groups. The three business segments include Supply Chain Management (SCM), Enterprise Resource Planning (ERP) and Information Technology (IT) Consulting

Perficient Inc. Commercial Scientific Research | St. Louis, MO

Perficient is a leading technology and management consulting firm serving clients throughout the United States. We are experts in designing, building and delivering business-driven technology solutions. We help our clients gain competitive advantage by using Internet-based technologies to make their businesses more responsive to market opportunities and threats, strengthen relationships with customers, suppliers and partners, improve productivity and reduce information technology costs. Since 1998, we have delivered successful business-driven technology solutions for hundreds of Global 2000 and other large enterprise customers. During that time, we have grown from a startup to an industry leader leading serving clients from a network of offices across North America and with global delivery centers in China, Eastern Europe and India. Deep domain expertise with a variety of technology platforms, strong partnerships with the world's leading vendors, dedicated industry expertise and a broad solutions portfolio differentiates our firm. We use small, expert project teams that deliver high-value, measurable results by working collaboratively with clients through a user-centered, technology-based and business-driven solutions methodology. We believe this approach enhances return-on-investment for our clients by significantly reducing the time and risk associated with designing and implementing business and technology solutions. Our work is routinely recognized by our partners, trade and industry authorities and most importantly, our clients. At Perficient, we place strong emphasis on building lasting relationships with clients and being 100% referenceable. In each of the past four years, more than 80% of our revenue was derived from repeat business. We believe this reflects our commitment to quality consulting and the long-term partnerships we build with our clients

Intervest Offices & Warehouses SA Real Estate | Antwerp, VL

Intervest Offices & Warehouses SA engages in the property investment fund business. It operates through the Offices and Logistics segments. The Offices segment provides the properties that are leased to companies for professional purposes as office space. The Logistics segment includes those premises with a logistical function, storage facilities, and high-tech buildings. The company was founded on August 8, 1996 and is headquartered in Antwerp, Belgium.

Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Boston Scientific Corporation Medical Products & Equipment - MARLBOROUGH, MA

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Cardiovascular, Rhythm Management, and MedSurg. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease, and other cardiovascular disorders including structural heart conditions. The Rhythm Management segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal, and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Allergan Plc Pharmaceuticals - Dublin, DU

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded on in 1984 and is headquartered in Dublin, Ireland.